Search
New Alzheimer’s Trial to Combine Anti-Amyloid and Anti-Tau Therapies to Arrest Disease Progression
A new study will combine an Alzheimer’s medication that slows disease progression in some patients with two drugs that target disease-driving proteins to see whether their effects can be amplified.Why Has Progress in the Treatment of Alzheimer’s Disease Taken 30 Years?
UCSF expert examines the past and future of clinical trials for Alzheimer’s Disease.Assessing Cognitive Decline in Primary Care: New Tools and Algorithms for Everyday Practice
Although timely diagnosis can significantly improve a patient’s future, dementia is underdiagnosed and often detected late.Slumber Secrets: New Insights into the Complexities of Sleep and Managing Common Issues
Sleep medicine specialist Rochelle Zak, MD, delivers a rousing update on what’s known about sleep’s stages and physiological payoffs, followed by her guide to assessing and treating insomnia – by far the main sleep issue seen in primary care.Assessing First Seizures: Steps for Primary Care Providers
Neurologist Manu Hegde, MD, PhD, breaks seizures into basic classes and puts the numerous epilepsy syndromes into three useful categories. He discusses how to take better histories; what to check for during physical exams; and what to know about antiseizure drugs, including specific side effects.